Dammann H G, Süssenbach J, Czok G
Klin Wochenschr. 1976 Aug 15;54(16):789-91. doi: 10.1007/BF01614296.
Bilary re-excretion of sulfobromophthalein sodium (BSP) (1.2 mumol/rat) after retrograde intrabilary injection is markedly inhibited by dehydrocholate sodium (Decholin) given intravenously as a constant infusion (3.1 mumol/min/kg body weight) or as a bolus injection (24.8 mumol/rat) to rats. Most interestingly Decholin demonstrates the same inhibitory effects on the biliary re-excretion of BSP when it is administered by retrograde intrabiliary injection (24.8 mumol/rat) together with the dye. In contrast to the inhibition of biliary re-excretion of BSP its biliary reabsorption from the biliary tract seems to be rather increased: about 80-85% of 1.2 mumol BSP are reabsorbed in all sets of experiments with Decholin in comparison to about 65% to the control group. Combined with histological data it is suggested that reabosorption of BSP after retrograde intrabiliary injection occurs at the ductular site whereas re-excretion takes place at the cannalicular membrane of the hepatocyte.
逆行胆管内注射磺溴酞钠(BSP,1.2微摩尔/大鼠)后,静脉持续输注(3.1微摩尔/分钟/千克体重)或推注(24.8微摩尔/大鼠)脱氢胆酸钠(去氢胆酸)可显著抑制大鼠胆汁中BSP的再排泄。最有趣的是,当脱氢胆酸与染料一起通过逆行胆管内注射(24.8微摩尔/大鼠)给药时,它对BSP的胆汁再排泄也表现出相同的抑制作用。与BSP胆汁再排泄受到抑制相反,其从胆道的胆汁重吸收似乎反而增加:在所有使用脱氢胆酸的实验中,1.2微摩尔BSP约80 - 85%被重吸收,而对照组约为65%。结合组织学数据表明,逆行胆管内注射后BSP的重吸收发生在胆小管部位,而再排泄发生在肝细胞的胆小管膜。